# Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine

> **NCT02513290** · PHASE4 · COMPLETED · sponsor: **Universidade do Sul de Santa Catarina** · enrollment: 73 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Bilastine
- **DRUG:** Loratadine

## Key facts

- **NCT ID:** NCT02513290
- **Lead sponsor:** Universidade do Sul de Santa Catarina
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2018-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02513290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02513290, "Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02513290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*